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The spatial heterogeneity of the oxygen tension (pO2) in human and experimental tumours has been studied extensively, whereas
studies of the temporal heterogeneity in pO2 are sparse. In the work reported here, pO2 was measured continuously over periods of
at least 60min in A-07 human melanoma xenografts by using the OxyLite fibre-optic oxygen-sensing device. The main purpose of the
work was to establish the usefulness of the OxyLite system in measuring the temporal heterogeneity in pO2 in tissues and to
characterise the fluctuations in tissue pO2 in A-07 tumours. The OxyLite device was found to be suitable for studies of the temporal
heterogeneity in pO2 in tumours. However, potential pitfalls were identified, and reliable pO2 measurements require that precautions
are taken to avoid these pitfalls, that is, erroneous pO2 readings caused by tissue trauma induced by the probe, probe movements
induced by reflex actions of the host mouse and occasional probe drift. Significant fluctuations in pO2 were detected in the majority
of the 70 tumour regions subjected to measurement. The fluctuations in different regions of the same tumour were in general
temporally independent, implying that they were caused primarily by redistribution of the tumour perfusion rather than fluctuations in
global perfusion. Fourier analysis of the pO2 traces showed that the pO2 usually fluctuated at frequencies lower than 1.5–2.0mHz,
corresponding to less than 0.1cyclemin
 1. Haemodynamic effects may cause pO2 fluctuations in this frequency range, and hence, the
redistribution of the perfusion could have been caused by morphological abnormalities of the tumour microvasculature. Moreover,
acute hypoxia, that is, pO2 fluctuations around 10 or 5mmHg, was detected in 20 of 70 regions, that is, 29% (10mmHg), or 27 of 70
regions, that is, 39% (5mmHg). The median fraction of the time these regions were acutely hypoxic was 73% (10mmHg) or 53%
(5mmHg). Consequently, if A-07 tumours are adequate models of tumours in man, acute hypoxia may be a commonly occurring
phenomenon in neoplastic tissues, and hence, acute hypoxia is likely to cause resistance to radiation therapy and promote tumour
aggressiveness.
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Most tumours are heterogeneous in oxygen tension (pO2) and
show regions with severely hypoxic cells (Vaupel et al, 1989). Two
main types of hypoxia have been recognised: chronic hypoxia,
arising from limitations in oxygen diffusion, and acute hypoxia,
resulting from transient cessations in microregional blood flow
(Horsman, 1995; Brown, 1999). Tumour hypoxia causes resistance
to radiation therapy and some forms of chemotherapy (Brown,
1999; Wouters et al, 2002) and promotes malignant progression
and the development of metastatic disease (Rofstad, 2000; Ho ¨ckel
and Vaupel, 2001). Clinical investigations have shown that
extensive hypoxia in the primary tumour is associated with
locoregional treatment failure and poor disease-free and overall
survival in several histological types of cancer (Rofstad, 2000;
Ho ¨ckel and Vaupel, 2001; Wouters et al, 2002).
The spatial heterogeneity in pO2 in tumours has been studied in
great detail (Vaupel et al, 1989; Vaupel, 1990). Steep gradients in
pO2 and pO2 values ranging from 0mmHg to those found in well-
oxygenated normal tissues are characteristic features of tumours,
implying that tumour tissues may show extensive spatial hetero-
geneity in cellular radiation sensitivity (Wouters and Brown, 1997)
and hypoxia-induced gene expression (Acker and Plate, 2002;
Harris, 2002). In contrast, studies of the temporal heterogeneity in
pO2 in tumours are sparse (Dewhirst et al, 2000). However,
examinations of fluctuations in microvessel blood flow in window
chamber tumours and measurements of the kinetics of red blood
cell flux in experimental and human solid tumours by laser
Doppler flowmetry have suggested that temporal heterogeneity in
pO2 and acute hypoxia are common events in tumour tissues
(Endrich et al, 1979; Brizel et al, 1993; Chaplin and Hill, 1995; Hill
et al, 1996). Moreover, radiobiological studies of murine tumours
and human tumour xenografts have given evidence that acute
hypoxia may be a significant cause of tumour radiation resistance
(Yamaura and Matsuzawa, 1979; Chaplin et al, 1987; Rofstad and
Ma ˚seide, 1999). Measurements of temporal heterogeneity in pO2,
however, have been reported for tumours of one line only, the rat
R3230Ac mammary adenocarcinoma. In these experiments,
recessed-tip oxygen microelectrodes (Linsenmeier and Yancey,
1987) were used to record fluctuations in pO2 in tumours
implanted subcutaneously (Dewhirst et al, 1998; Braun et al,
1999) or in window chambers (Dewhirst et al, 1996; Kimura et al, Revised 14 March 2003; accepted 27 April 2003
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s1996). The studies suggested that tissue pO2 and red blood cell flux
fluctuated at low frequencies and were temporally coordinated,
and demonstrated that acute hypoxia is a frequently occurring
phenomenon in R3230Ac tumours (Dewhirst et al, 1996, 1998;
Kimura et al, 1996; Braun et al, 1999).
The low number of investigations of the temporal heterogeneity
in pO2 in tumours most likely reflects that adequate equipment for
measurement of fluctuations in pO2 in tissues has not been
commercially available (Dewhirst et al, 2000). A new oxygen-
sensing device, the OxyLite system, was marketed recently (Young
et al, 1996; Griffiths and Robinson, 1999). This device measures
pO2 by using a fluorescence quenching technique. Light pulses
induce fluorescence in ruthenium chloride incorporated into a
silicone rubber polymer at the tip of 220-mm-diameter fibre-optic
probes. The lifetime of the fluorescence is inversely proportional to
the oxygen tension at the probe tip. Comparative studies have
shown that tumour pO2 distributions and hypoxic fractions
measured with the OxyLite system are similar to those obtained
with Eppendorf polarographic electrodes (Collingridge et al, 1997;
Seddon et al, 2001), recessed-tip microelectrodes (Braun et al,
2001) and radiobiological assays (Urano et al, 2002). The OxyLite
system has been used successfully to measure pO2 changes in
experimental tumours following different types of physiological
intervention (Bussink et al, 2000; Braun et al, 2001;Demeure et al,
2002; Jarm et al, 2002; Jordan et al, 2002).
In the work reported here, the OxyLite system was used to
measure pO2 fluctuations in unperturbed A-07 human melanoma
xenografts transplanted orthotopically in BALB/c-nu/nu mice.
Xenografted A-07 tumours have been shown to retain many
biological characteristics of the donor patient’s tumour, including
cell cycle distribution, angiogenic potential, vascular density,
metastatic pattern and several histological and pathophysiological
parameters (Rofstad, 1994). The main purpose of the work was to
establish the usefulness of the OxyLite system in studying the
temporal heterogeneity in pO2 in tissues and to characterise the
pO2 fluctuations in a clinically relevant tumour model. Significant
evidence was found that the pO2 in many tumour regions
fluctuated around the threshold values for hypoxia-induced
radiation resistance and hypoxia-induced gene expression.
MATERIALS AND METHODS
Mice and tumours
Adult (8 10 weeks of age) female BALB/c-nu/nu mice were used as
host animals for xenografted tumours. The mice were maintained
under specific pathogen-free conditions at constant temperature
(37.070.51C) and humidity (50 60%). Sterilised food and water
were given ad libitum. Experiments were performed with tumours
of the A-07 human melanoma line, established as described
previously (Rofstad, 1994). Tumours were initiated from exponen-
tially growing cell cultures verified to be free from Mycoplasma
contamination. The cells were cultured in RPMI-1640 medium
(25mM HEPES and L-glutamine) supplemented with 13% bovine
calf serum, 250mgl
 1 penicillin and 50mgl
 1 streptomycin.
Approximately 3.5 10
5 cells in 10mlo fC a
2þ and Mg
2þ-free
Hanks’ balanced salt solution were inoculated intradermally into
the hindmost part of the left mouse flank by using a 100-ml
Hamilton syringe. The tumours were subjected to measurements of
pO2 when having volumes within the range of 300 700mm
3.
Tumour volume (V) was calculated as V¼(p/6)ab
2, where a is the
longer and b is the shorter of two perpendicular diameters,
measured with calipers. Animal experiments were approved by the
Institutional Committee on Research Animal Care and were
performed in accordance with the ethical standards of the
UKCCCR ‘Guidelines for the Welfare of Animals in Experimental
Neoplasia’ (Workman et al, 1998).
Measurement of pO2
Tumour pO2 was measured with a two-channel fibre-optic oxygen-
sensing device (OxyLitet 2000, Oxford Optronix, Oxford, UK).
The probes were supplied precalibrated by the manufacturer. The
calibration data were scanned into a computer by means of a
barcode wand. The calibration specification was 70.7mmHg or
o710% of actual pO2, whichever was greater. To ensure correct
pO2 readings, the accuracy of the precalibration data was
controlled for every probe by measuring pO2 in Ringers solutions
flushed with N2 gas containing 0, 0.5, 1.0, 2.5 or 5.0% O2. This
procedure was repeated at the end of each experiment to control
for drift in the system. Atmospheric pressure was measured with
a DPI 705 barometer (Newport Electronics, Deckenpfronn,
Germany).
The mice were kept under anaesthesia during the pO2
measurements. A mixture of fentanyl citrate/fluanisone (Janssen
Pharmaceutika, Beerse, Belgium) and midazolam (Roche, Basel,
Switzerland) was administered intraperitoneally in doses of 0.63/20
and 10mgkg
 1, respectively. The body core temperature of the
mice, measured with a rectal probe, was kept at 37.5–38.01Cb y
using a heating lamp and a heating pad. The tumour temperature
under these conditions, measured with an OxyLite probe having a
fine thermocouple wound around the optic fibre, was within 37.0–
38.01C, that is, it was similar to the tumour temperature during the
growth period prior to the pO2 measurements.
Most tumours had an ellipsoidic shape, and tissue pO2 was
measured simultaneously in two positions in each tumour, that is,
centrally in each of the two halves of the ellipsoid. The probes were
inserted into the tumours through skin punctures made with 21- or
23-gauge needles. After insertion, the probes were retracted by
approximately 1mm to minimise the pressure on the sensors
before they were fixed firmly and pO2 measurements were
initiated. The pO2 readings were recorded every 5, 10 or 30s for
at least 60min and were stored to disc and displayed as time traces
by using a data-acquisition system (LabView, National Instru-
ments, Austin, TX, USA). The mice were watched continuously
during the experiments and reflex movements were recorded. At
the end of the experiments, the mice were killed without
withdrawing the probes from the tumour tissue, and it was
ensured that the pO2 dropped rapidly to 0mmHg. Data were
discarded if (a) changes in tumour pO2 were associated with reflex
movements of the host mouse, (b) tumour pO2 did not drop to
0mmHg after killing of the host mouse or (c) the probe calibration
at the end of an experiment gave data that differed significantly
from the precalibration data.
Fourier analysis
Characteristic frequencies of pO2 fluctuations were searched for by
subjecting the pO2 traces (oxygen tension vs time) to Fourier
analysis. The Fourier analysis was performed by using IDL
software (Research Systems, Boulder, CO, USA). The program
calculated frequency spectra from pO2 traces by accomplishing a
discrete Fourier transformation. The highest detectable frequency
was given by the sampling frequency and was 100mHz at a
sampling frequency of 5s. The lowest detectable frequency was
given by the length of the observation period and was
approximately 0.4mHz at an observation period of 40min.
RESULTS
Measurement of pO2 in A-07 tumours with OxyLite probes gave
values that varied substantially with time. The variations were
more pronounced shortly after the probe insertion than towards
the end of the observation period. Two characteristic pO2 traces
are illustrated in Figure 1A. The initial pO2 was above 5mmHg in
both traces. In trace #1, the pO2 decreased for several minutes
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sbefore it increased gradually and reached a high and fairly stable
level. In trace #2, the pO2 decreased rapidly with time before a low
and fairly stable level was reached. To investigate whether the
initial changes in pO2 were artefacts caused by the probe insertion,
similar pO2 measurements were performed in muscle tissue in
BALB/c-nu/nu mice. Two typical pO2 traces from muscle tissue are
presented in Figure 1B. The muscle pO2 traces were qualitatively
similar to pO2 trace #1 in Figure 1A, strongly suggesting that the
initial pO2 changes were artefacts.
To determine the length of the time period in which the pO2
readings in A-07 tumours obviously were influenced by the probe
insertion, 50 randomly selected pO2 traces were normalised and
summed. The normalisation was performed by dividing all pO2
values in a trace by the highest pO2 value recorded in that trace,
excluding pO2 values recorded during the first 10min when
determining the normalisation factor. The pO2 trace representing
the sum of the normalised pO2 traces is plotted in Figure 2. This
plot suggests that the changes in pO2 recorded within the first
20min after the probe insertion were systematic and hence were
artefacts caused by the probe, whereas the pO2 changes recorded
beyond 20min were random and hence most likely represented
true variations in tissue pO2. Consequently, the temporal hetero-
geneity in pO2 in A-07 tumours was studied by only considering
pO2 values recorded beyond the first 20min after the insertion of a
probe, that is, the first 20min of each pO2 trace was excluded in the
analysis presented below.
A total of 38 A-07 tumours were subjected to pO2 measurements
and a total of 70 reliable pO2 traces were obtained. The pO2 traces
showed substantial differences, regardless of whether they were
recorded in the same tumour or in different tumours. Mean pO2
differed among the traces from 0 to 38mmHg. Examples of
characteristic pO2 traces are illustrated in Figure 3. Both well-
oxygenated and poorly oxygenated tumour regions could show
pO2 traces without significant fluctuations (Figure 3A). However,
significant pO2 fluctuations were detected in most tumour regions
(Figure 3B). The pO2 traces were analysed by using two threshold
values for hypoxia, that is, pO2¼5 and 10mmHg. Some tumour
regions were not hypoxic at all during the observation period,
whereas others were hypoxic during the entire period (Table 1).
Acute hypoxia, that is, pO2 fluctuations around the threshold
values, was detected in 29% (10mmHg) and 39% (5mmHg) of the
tumour regions. To characterise the kinetics of the acute hypoxia,
the number of times per hour the pO2 decreased below the
threshold values and the fractional time the pO2 was below the
threshold values were calculated for each of the tumour regions
showing acute hypoxia. The durations of the hypoxic periods were
also determined. The median values and the ranges of these
parameters are presented in Table 1. A similar analysis has been
performed previously for R3230Ac rat tumours (Dewhirst et al,
1998), and the results of this analysis were included in Table 1 for
comparison.
Two pO2 traces were recorded simultaneously in most tumours.
None of the traces, one of the traces, or both traces could show
significant pO2 fluctuations. The pO2 values of concurrent traces
were subjected to correlation analysis to investigate whether the
pO2 fluctuations in different regions of the same tumour were
temporally coordinated. Positive correlations were found in some
tumours (Figure 4A), whereas inverse correlations were seen in
others (Figure 4B). However, there was no correlation between the
two series of pO2 values in the majority of the tumours, implying
that the pO2 fluctuations in different regions of a tumour in general
were temporally independent.
Moreover, the pO2 traces were subjected to Fourier analysis to
investigate whether the pO2 fluctuated at characteristic frequen-
cies. The Fourier analysis resulted in frequency spectra that were
not qualitatively different, regardless of whether they were derived
from the same tumour or from different tumours. The frequency
spectra indicated that the pO2 fluctuated at very low frequencies,
that is, at frequencies lower than 1.5–2.0mHz, corresponding to
less than 0.1 cycle min
 1. Significant fluctuations at higher
frequencies could not be detected. Data from a characteristic
tumour region are presented in Figure 5, showing the pO2 trace
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Figure 1 Examples of pO2 traces recorded with OxyLite probes in A-07
tumours (A) and muscle tissue (B). The traces show that the changes in
pO2 were more pronounced shortly after the probe insertion than towards
the end of the observation period.
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Figure 2 Sum of 50 normalised pO2 traces recorded with OxyLite
probes in A-07 tumours. The composed trace shows that the changes in
pO2 recorded within the first 20min after the probe insertion were
systematic, whereas those recorded beyond the first 20min were random.
Fluctuations in pO2
KG Brurberg et al
352
British Journal of Cancer (2003) 89(2), 350–356 & 2003 Cancer Research UK
E
x
p
e
r
i
m
e
n
t
a
l
T
h
e
r
a
p
e
u
t
i
c
s(Figure 5A) and the corresponding frequency spectrum
(Figure 5B).
DISCUSSION
Tissue pO2 in A-07 human melanoma xenografts was monitored
continuously over periods of at least 60min by using OxyLite
fibre-optic probes. The study showed that fluctuations in pO2 at
the microregional level occur frequently in A-07 tumours. More-
over, acute hypoxia was found to be a common phenomenon in
these tumours, which is in agreement with the conclusions from a
previous study in which radiobiological and immunohistochemical
assays were used to detect hypoxia in A-07 and other human
melanoma xenografts (Rofstad and Ma ˚seide, 1999). The OxyLite
system has been used previously to study changes in tumour pO2
following treatment with blood flow and tissue oxygenation
modifying agents (Bussink et al, 2000; Braun et al, 2001;Demeure
et al, 2002; Jarm et al, 2002; Jordan et al, 2002). The present study
is the first in which the OxyLite system has been used successfully
to study temporal heterogeneity in pO2 in unperturbed tumours.
Studies of temporal heterogeneity in pO2 in tumour tissue with
the OxyLite system, however, require precautions against potential
methodical pitfalls, as revealed by the work reported here. First, it
was observed that the pO2 values recorded shortly after the probe
was inserted into tumour tissue varied systematically with time
and hence were influenced signifcantly by the probe insertion. A
similar artefact was seen when tissue pO2 was measured in P22 rat
carcinosarcomas with OxyLite probes (Seddon et al, 2001). The
pO2 readings stabilised after approximately 10min in P22 tumours,
whereas in A-07 tumours, reliable pO2 readings could not be
obtained until 20min after the probe insertion. The artificial pO2
readings obtained during the first 20min of measurement in A-07
tumours were most likely a result of vasoconstrictive reactions to
tissue trauma induced by the probe. However, other factors may
also have contributed, as discussed in detail for P22 tumours
(Seddon et al, 2001). Second, it was observed that abrupt changes
in the pO2 readings could occur simultaneously with reflex
movements of the host mouse. These changes did probably not
reflect temporal heterogeneity in pO2, but were rather a
consequence of minor changes in probe position and hence the
spatial heterogeneity in pO2, as it is well known that tumour tissues
can show steep pO2 gradients (Vaupel, 1990; Horsman, 1995;
Braun et al, 2001; Urano et al, 2002). Third, it was observed that
some correctly precalibrated probes after a few measurements in
tissue suddenly began recording erroneous absolute values of pO2.
Therefore, it is essential to kill the host animals after each
experiment and ensure that the pO2 drops rapidly to 0mmHg, and
to control the probe calibration regularly in Ringers solutions, as
was followed in the work reported here.
Our analysis was based on the assumption that the pO2 readings
recorded beyond the first 20min after the probe insertion were not
influenced significantly by the tissue trauma caused by the probe.
The OxyLite probes have a tip diameter of 220mm and may
therefore now and then cause severe tissue damage during the
insertion, for example by destroying or compressing larger vessels.
Consequently, it cannot be excluded that the pO2 readings in some
of the tumour regions studied here were influenced by probe-
induced tissue damage also beyond the first 20min. However,
several observations suggest that this potential problem, if present,
was of minor significance. First, pO2 was measured in normal
tissues also, and significant pO2 fluctuations were never observed
beyond 20min, as illustrated for muscle tissue in Figure 1B.
Second, we have shown that the mean pO2 measured beyond
20min is inversely correlated to the fraction of radiobiologically
hypoxic cells in A-07 and R-18 human melanoma xenografts
(Brurberg et al, unpublished data). Moreover, comparative studies
performed in other laboratories have demonstrated that the pO2
distributions measured in experimental tumours with OxyLite
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Figure 3 Examples of pO2 traces recorded with OxyLite probes in A-07
tumours. The traces refer to tumour regions without significant fluctuations
in pO2 (A) and tumour regions showing significant fluctuations in pO2
around pO2 values of 5 and 10mmHg (B).
Table 1 Parameters describing the kinetics of acute hypoxia in A-07 human melanoma xenografts and R3230Ac rat mammary adenocarcinomas
A-07 R3230Ac
a
Parameter pO2o10mmHg pO2o5mmHg pO2o10mmHg pO2o5mmHg
Tumour regions that were never hypoxic (%) 17 (12/70) 30 (21/70) 15 (2/13) 38 (5/13)
Tumour regions that were always hypoxic (%) 54 (38/70) 31 (22/70) 23 (3/13) 23 (3/13)
Tumour regions showing acute hypoxia (%) 29 (20/70) 39 (27/70) 62 (8/13) 38 (5/13)
Hypoxic periods per pO2 trace per hour (#h
 1) 2.7 (1.1–8.5)
b 4.3 (1.1–12.0) 6.7 (2.7–24.0) 3.9 (0.9–17.9)
Fractional time of hypoxia per pO2 trace (%) 73.0 (1.9–99.5) 53.4 (4.3–97.9) 59.5 (30.8–90.0) 60.1 (16.2–84.7)
Duration of hypoxic periods (min) 4.6 (0.5–49.5) 2.0 (0.5–44.0) 5.0 (1.2–16.6) 7.4 (0.9–44.7)
aData from Dewhirst et al (1998).
bMedian value and range.
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sprobes are similar to those obtained with Eppendorf polarographic
electrodes (Collingridge et al, 1997; Seddon et al, 2001) and
recessed-tip microelectrodes (Braun et al, 2001).
Previous studies of the rat R3230Ac mammary adenocarcinoma
have led to the suggestion that fluctuations in tissue pO2 and acute
hypoxia may be commonly occurring phenomena in tumours
(Dewhirst et al, 1996, 1998; Kimura et al, 1996; Braun et al, 1999).
The present study of A-07 human melanoma xenografts, which
have been shown to retain several characteristic biological features
of the donor patient’s tumour (Rofstad, 1994) and hence most
likely are more relevant models of tumours in man than are
R3230Ac tumours, confirmed this suggestion. A direct comparison
of the temporal heterogeneity in pO2 in A-07 and R3230Ac
tumours is difficult, however, because OxyLite fibre-optic probes
were used to measure pO2 in the present work and recessed-tip
microelectrodes were used to measure pO2 in the R3230Ac
tumours. The tip diameter of the OxyLite probes is 220mm, and
the sampling volume has been estimated to be approximately 1000
cells (Griffiths and Robinson, 1999; Seddon et al, 2001). In
contrast, the recessed-tip microelectrodes had a diameter of only
10–12mm (Dewhirst et al, 1998), and therefore, they had a
sampling volume that was substantially smaller than that of the
OxyLite probes (Braun et al, 2001). Since tumours are spatially
heterogeneous in pO2 at the microregional level (Vaupel, 1990;
Horsman, 1995), microelectrodes are expected to measure larger
fluctuations in pO2 in tumours than are OxyLite probes (Braun
et al, 2001). Nevertheless, the temporal heterogeneity in pO2
measured in A-07 tumours was remarkably similar to that
measured in R3230Ac tumours, as can be seen from the
comparison of A-07 and R3230Ac tumours presented in Table 1.
Temporal heterogeneity in pO2 in tumour tissue has to be
caused by temporal heterogeneity in either oxygen delivery, that is,
blood supply, or oxygen consumption, that is, cell respiration, or
both. There is no experimental evidence that the rate of respiration
may fluctuate synchronously in cells within tumour microregions.
On the other hand, there is ample evidence that the blood supply
may fluctuate significantly at the microregional level in both
experimental and human tumours (Endrich et al, 1979; Brizel et al,
1993; Chaplin and Hill, 1995; Hill et al, 1996). Studies of R3230Ac
tumours transplanted to window chambers have suggested that the
fluctuations in pO2 in these tumours were temporally coordinated
with fluctuations in red blood cell flux (Dewhirst et al, 1996;
Kimura et al, 1996). Moreover, Fourier analysis of pO2 traces
recorded with recessed-tip microelectrodes and red blood cell flux
traces recorded by laser Doppler flowmetry revealed that both pO2
and blood flow fluctuated at very low frequencies in subcutaneous
R3230Ac tumours (Braun et al, 1999). The data reported here for
A-07 tumours are in good agreement with those of the R3230Ac
tumours. Thus, the pO2 frequency spectra of the A-07 tumours
suggested that the pO2 fluctuated at low frequencies also in these
tumours, that is, at frequencies lower than 1.5–2.0mHz, corre-
sponding to less than 0.1cyclemin
 1. Fluctuations in pO2 in this
frequency range could result from fluctuations in blood flow
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Figure 4 Examples of pO2 traces recorded simultaneously with OxyLite
probes in two regions of the same A-07 tumours. The traces refer to a
tumour where the pO2 values were correlated (A) and a tumour where
the pO2 values were inversely correlated (B).
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Figure 5 Example of a pO2 trace recorded with an OxyLite probe in an
A-07 tumour (A) and the corresponding frequency spectrum (B). The
frequency spectrum, which was obtained by subjecting the pO2 data to
Fourier analysis, suggests that the pO2 fluctuated at frequencies lower than
1.5–2.0mHz.
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scaused by vasomotion in supplying arterioles, haemodynamic
mechnisms and/or microvascular remodelling via intussusceptive
vascular growth (Braun et al, 1999). Haemodynamic mechanisms
may be particularly significant because the blood viscosity is
elevated in tumour tissues and the tumour microvascular network
is irregular and chaotic (Vaupel et al, 1989).
Studies of intratumour heterogeneity in temporal variation in
pO2 have not been reported so far. The pO2 measurements
performed in R3230Ac tumours were all restricted to a single point
at a time in each tumour (Dewhirst et al, 1996, 1998; Kimura et al,
1996; Braun et al, 1999). Therefore, these studies did not provide
information on the fractional tumour volume showing pO2
fluctuations or on the temporal coordination of the pO2
fluctuations in different tumour regions. Attempts to obtain
information of this type were made in the present work by
measuring pO2 simultaneously in two distinctly different regions of
the same A-07 tumours. In some tumours, significant fluctuations
in pO2 could not be detected in any of the regions, and in others,
pO2 fluctuated significantly in one of the regions only, suggesting
that the pO2 fluctuations usually involved only a fraction of the
tumour volume. Many A-07 tumours, however, showed significant
pO2 fluctuations in both regions. These fluctuations were in
general not temporally coordinated, suggesting that they were
caused primarily by redistribution of the perfusion within the
tumours rather than changes in global perfusion. Thus, in some
tumours, the pO2 values in the two regions analysed simulta-
neously were inversely correlated. However, our experiments can
by no means exclude the possibility that also the global perfusion
and hence the fraction of acutely hypoxic cells varied significantly
with time. In fact, this possibility is very likely, considering the
irregular and heterogeneous nature of the microvasculature of
tumours, and is supported by the observation that the two pO2
series recorded simultaneously were strongly correlated in some
tumours. Studies of temporal heterogeneity in pO2 involving
mapping of the pO2 distribution in whole tumours are needed,
however, before this question can be settled.
The study reported here may have significant implications for
the radiation therapy of cancer. First, clinical studies attempting to
eliminate the chronic hypoxia in tumours during radiation therapy
are being performed, but so far, the therapeutic results have been
unsatisfactory (Overgaard and Horsman, 1996). The present
observations suggest that a significant fraction of the hypoxic
cells in tumours are acutely hypoxic, and acutely hypoxic cells may
be more resistant to radiation therapy than chronically hypoxic
cells (Pettersen and Wang, 1996; Zo ¨lzer and Streffer, 2002).
Consequently, treatment strategies aiming at reducing the fraction
of acutely hypoxic cells may prove more successful in improving
the outcome of radiation therapy than those aiming at reducing the
fraction of chronically hypoxic cells. Second, serious attempts have
been initiated to improve the local control of radiation-resistant
tumours by using intensity modulated radiation therapy for
selective boosting of hypoxic subvolumes (Tome and Fowler,
2000; Chao et al, 2001; Popple et al, 2002). Our observations
suggest that the spatial distribution of the acutely hypoxic regions
in tumours may change rapidly with time. Consequently, efficient
selective boosting of hypoxic subvolumes may require novel
technology for imaging of tumour hypoxia and guiding of
intensity-modulated radiation therapy.
The present observations are also relevant for our under-
standing of the malignant progression of tumours and the
development of metastatic disease. It is well established that
tumour hypoxia activates DNA transcription factors, for example,
HIF-1, and leads to increased expression of a large number of
genes, and a high expression of these genes has been shown to be
associated with poor prognosis in several histological types of
cancer (Rofstad, 2000; Ho ¨ckel and Vaupel, 2001; Acker and Plate,
2002; Harris, 2002; Wouters et al, 2002). Some of the genes that are
activated under hypoxic conditions encode proteins involved in
the metastatic process, for example, angiogenesis factors and
proteolytic enzymes. Studies of human melanoma xenografts have
shown that tumour hypoxia may promote metastasis by upregu-
lating the expression of interleukin-8 (Rofstad and Halsr, 2002)
and urokinase-type plasminogen activator receptor (Rofstad et al,
2002). The study reported here showed that a significant fraction
of the hypoxic volume of tumours may be acutely hypoxic and that
the spatial distribution of the acutely hypoxic regions may change
rapidly with time. It is possible that the dynamic nature of the
acute hypoxia in tumours may lead to hypoxia-induced gene
expression without loss of viability in a substantial fraction of the
malignant cells and hence may promote aggressiveness and
metastatic spread. Consistent with this suggestion is the observa-
tion that experimentally imposed acute hypoxia but not chronic
hypoxia-enhanced spontaneous metastasis in KHT murine tu-
mours (Cairns et al, 2001).
In summary, the present study showed that significant
fluctuations in tissue pO2 and acute hypoxia are commonly
occurring phenomena in A-07 human melanoma xenografts. If A-
07 tumours are relevant models of tumours in man, acute hypoxia
may be an important cause of resistance to radiation therapy and
malignant progression in human cancer.
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